Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeHealth

      Health

      No serious adverse events to date in ongoing phase 1/2a clinical study of SYN321
      Health

      No serious adverse events to date in ongoing phase 1/2a clinical study of SYN321

      January 9, 2026
      Saluda Medical Receives Regulatory Approval for EVA™ Sensing Technology in Europe with recognition in Australia
      Health

      Saluda Medical Receives Regulatory Approval for EVA™ Sensing Technology in Europe with recognition in Australia

      January 8, 2026
      Orbis International Appoints John Slattery as Chair of the Board of Directors
      Health

      Orbis International Appoints John Slattery as Chair of the Board of Directors

      January 7, 2026
      epiq Animal Health and Vetramil to Offer Specially Formulated Animal Skincare Products
      Health

      epiq Animal Health and Vetramil to Offer Specially Formulated Animal Skincare Products

      January 6, 2026
      CivicaScript announces availability of low-cost insulin and biosimilar for chronic inflammatory conditions in the US
      Health

      CivicaScript announces availability of low-cost insulin and biosimilar for chronic inflammatory conditions in the US

      January 5, 2026
      Sumbu Unveils World’s First Dual-Vector Consumer Exoskeleton at CES 2026
      Health

      Sumbu Unveils World’s First Dual-Vector Consumer Exoskeleton at CES 2026

      January 4, 2026
      CMS Rural Health Awards Highlight the Need to Support Rural Health Care
      Health

      CMS Rural Health Awards Highlight the Need to Support Rural Health Care

      January 3, 2026
      Bebird Launches EarSight Ultra X: The 5G-Powered Ear Care Solution for Modern Families Pursuing a Quality Life
      Health

      Bebird Launches EarSight Ultra X: The 5G-Powered Ear Care Solution for Modern Families Pursuing a Quality Life

      January 2, 2026
      PLATINUM EQUITY COMPLETES ACQUISITION OF OWENS & MINOR PRODUCTS & HEALTHCARE SERVICES BUSINESS
      Health

      PLATINUM EQUITY COMPLETES ACQUISITION OF OWENS & MINOR PRODUCTS & HEALTHCARE SERVICES BUSINESS

      January 1, 2026
      Canada’s Largest Cold Plunge Returns to Woodbine Beach on New Year’s Day
      Health

      Canada’s Largest Cold Plunge Returns to Woodbine Beach on New Year’s Day

      December 31, 2025
      1 2 3 … 236 »

       

      LATEST NEWS

      • Investing News Starbucks Store Portfolio Reset Boosts Unit Economics
      • Investing News Uber Q4 2025 Earnings: What Investors Should Know
      • Investing News Samsung’s Profit Surge in Q4 2026
      • Investing News NinjaOne Surpasses $500M ARR Milestone
      • Investing News Nvidia and Foxconn Revenue Surge

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026